Patent ID: 11945787
Assignee: ELA PHARMA LTD
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 2:
3. The method of claim 1, wherein:
(i) G1 is pyrrolidinyl; and
G2 is alkyl, cyclopropyl, cyclobutyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, or aryl;
wherein the heterocyclyl contains 1, 2, 3, or 4 heteroatoms independently selected from the group consisting of N and S;
wherein the alkyl is substituted with one or more substituents independently selected from the group consisting of halogen, NO2, CN, C1-C6 alkyl, C1-C6 haloalkyl, NH2, OH, OC1-C6 alkyl, C(O)H, C(O)C1-C6 alkyl, C(O)NH2, C(O)OH, and C(O)OC1-C6 alkyl; and
wherein the cyclopropyl, cyclobutyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, or aryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, NO2, CN, C1-C6 alkyl, C1-C6 haloalkyl, NH2, OH, OC1-C6 alkyl, C(O)H, C(O)C1-C6 alkyl, C(O)NH2, C(O)OH, and C(O)OC1-C6 alkyl; or

(ii) G1 is piperidinyl, wherein the piperidinyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, NO2, CN, C1-C6 alkyl, C1-C6 haloalkyl, NH2, OH, OC1-C6 alkyl, C(O)H, C(O)C1-C6 alkyl, C(O)NH2, C(O)OH, and C(O)OC1-C6 alkyl; and
G2 is cycloalkyl, heterocyclyl, or aryl, wherein the cycloalkyl, heterocyclyl, or aryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, NO2, CN, C1-C6 alkyl, C1-C6 haloalkyl, NH2, OH, OC1-C6 alkyl, C(O)H, C(O)C1-C6 alkyl, C(O)NH2, C(O)OH, and C(O)OC1-C6 alkyl; or

(iii) G1 is piperazinyl, wherein the piperazinyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, NO2, CN, C1-C6 alkyl, C1-C6 haloalkyl, NH2, OH, OC1-C6 alkyl, C(O)H, C(O)C1-C6 alkyl, C(O)NH2, C(O)OH, and C(O)OC1-C6 alkyl; and
G2 is cycloalkyl, heterocyclyl, or aryl;
wherein the heterocyclyl contains 1, 2, 3, or 4 heteroatoms independently selected from the group consisting of N and S; and
wherein the cycloalkyl, heterocyclyl, or aryl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, NO2, CN, C1-C6 alkyl, C1-C6 haloalkyl, NH2, OH, OC1-C6 alkyl, C(O)H, C(O)C1-C6 alkyl, C(O)NH2, C(O)OH, and C(O)OC1-C6 alkyl.